Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M

Drug Development and Industrial Pharmacy

Volumn 38, Issue 5, 2012, Pages 515-520

  Lamoudi, Lynda ^a   Chaumeil, Jean Claude ^b   Daoud, Kamel ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

acryl EZE; dissolution kinetic; fluidized bed; hydroxypropyl methylcellulose; Sodium diclofenac; tablets matrix; wet granulation

Indexed keywords

DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; POLYMETHACRYLIC ACID DERIVATIVE;

DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FLUIDIZED BED; KINETICS; MATRIX TABLET; PH; REVIEW; STOMACH JUICE; SUSTAINED RELEASE PREPARATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; BONE CEMENTS; CELLULOSE; DELAYED-ACTION PREPARATIONS; DICLOFENAC; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, THEORETICAL; POLYMETHYL METHACRYLATE; SOLUBILITY; TABLETS;

EID: 84859300847     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.620966     Document Type: Review

References (35)

1. Caraballo Isidoro. (2010). Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories. Expert Opin Drug Deliv 7:1291-1301.
2. De Castro WV, Pires MA, Oliveira MA, Vianna-Soares CD, Nunan EA, Pianetti GA et al. (2006). The influence of formulation on the dissolution profile of diclofenac sodium tablets. Drug Dev Ind Pharm, 32:1103-1109. (Pubitemid 44521828)
3. Dreu Rok, Ilić Ilija, Srečieč Stanko. (2011). Development of a multiple-unit tablet containing enteric-coated pellets. Drug Dev Ind Pharm, 16:118-126.
4. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. (1988). Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29:1035-1041.
5. Faith A. Chaibva, Sandile M.M. Khamanga, Roderick B. Walker. (2010). Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets. Drug Dev Ind Pharm, 36:1497-1510.
6. Ford JL, Rubinstein MH, Hogan JH. (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices. Int J Pharm, 24:327-338. (Pubitemid 15062540)
7. Ford JL, Rubinstein MH, Hogan JE. (1985). Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropylmethylcellulose. Int J Pharm, 24:339-350. (Pubitemid 15062541)
8. Fu XC, Wang GP, Liang WQ, Chow MS. (2004). Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release, 95:209-216. (Pubitemid 38230036)
9. Gurny R, Doelker E, Peppas NA. (1982). Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers. Biomaterials, 3:27-32. (Pubitemid 12104449)
10. Guidance for industry. August 1997. Dissolution testing of immediate release solid oral dosage forms. US Department of Health and Human Services, CDER.
11. Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50:874-875.
12. Higuchi T. (1963). Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52:1145-1149.
13. Khanna R, Agarwal SP, Ahuja A. (1997). Muco-adhesive buccal tablets of clotrimazole for oral candidiasis. Drug Dev Ind Pharm, 23:831-837. (Pubitemid 27325711)
14. Kiortsis S, Kachrimanis K, Broussali T, Malamataris S. (2005). Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur J Pharm Biopharm, 59:73-83. (Pubitemid 39573439)
15. Korsmeyer RW, Gurnya R, Doelker E, Buri P, Peppas NA. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 15, 25-35. (Pubitemid 13092121)
16. Lee BJ, Ryu SG, Cui JH. (1999). Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm, 25:493-501.
17. Li CL, Martini LG, Ford JL, Roberts M. (2005). The use of hypromellose in oral drug delivery. J Pharm Pharmacol, 57:533-546. (Pubitemid 40562392)
18. Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. (2003). Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm, 253:13-22. (Pubitemid 36197827)
19. Madhusudan Rao Y, Krishna Veni J, Jayasagar G. (2001). Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev Ind Pharm, 27:759-766. (Pubitemid 33029501)
20. Melia CD. (1991). Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit Rev Ther Drug Carrier Syst, 8:395-421.
21. Miranda A, Millán M, Caraballo I. (2006). Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int J Pharm, 311:75-81.
22. Nizar M. Al-Zoubi, Hatim S. AlKhatib,and Wasfy M. Obeidat (2011). Evaluation of hydrophilic matrix tablets based on Carbopol® 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Development and Industrial Pharmacy, 7:789-808.
23. Nunthanid J, Huanbutta K, Luangtana-Anan M, Sriamornsak P, Limmatvapirat S, Puttipipatkhachorn S. (2008). Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose. Eur J Pharm Biopharm, 68:253-259.
24. Nykänen P, Krogars K, Säkkinen M, Heinämäki J, Jürjensson H, Veski P et al. (1999). Organic acids as excipients in matrix granules for colon-specific drug delivery. Int J Pharm, 184:251-261. (Pubitemid 29317659)
25. Omidian H, Park K. (2008). Swelling agents and devices in oral drug delivery. J Drug Deliv Sci Tech, 2, 83-93. (Pubitemid 351449969)
26. Peppas NA, Sahlin J. (1989). A simple equation for the description of solute release. III: Coupling of diffusion and relaxation. Int J Pharm, 57:169-172. (Pubitemid 20011841)
27. Perez-Marcos B, Ford JL, Armstrong DJ, Elliott PN, Rostron C, Hogan JE. (1996). Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropylmethylcellulose K4M and carbopol 974. J Pharm Sci, 85:330-334. (Pubitemid 26084361)
28. Pygall SR, Kujawinski S, Timmins P, Melia CD. (2009). Mechanisms of drug release in citrate buffered HPMC matrices. Int J Pharm, 370:110-120.
29. Quintanar-Guerrero D, Ganem-Quintanar A, Raygoza-Trejo D, Doelker E. (1999). Relationship between the swelling process and the release of a water-soluble drug from a compressed swellable-soluble matrix of poly(vinyl alcohol). Drug Dev Ind Pharm, 25:169-174. (Pubitemid 29072778)
30. Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release, 5:37-42. (Pubitemid 17106644)
31. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced Drug Delivery Reviews, 48:139-157. (Pubitemid 32434400)
32. Siepmann J, Siepmann F. Mathematical modeling of drug delivery. (2008). Int J Pharm, 364:328-343.
33. Singh B, Rani A, Babita, Ahuja N, Kapil R. (2010). Formulation Optimization of Hydrodynamically Balanced Oral Controlled Release Bioadhesive Tablets of Tramadol Hydrochloride. Sci Pharm, 78:303-323.
34. Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. (2005). Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm, 31:653-665. (Pubitemid 41356208)
35. Lachmann L, Lieberman HA, Kaning J. (2001). teoria e pràtica na industria farmacèutica. Lisboa. vol 2. Fundacào Calouste Gulbenkan, Lisboa. pp 509-597.